First Trust Advisors’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
Other funds holding CLYM
First Trust Advisors's CLYM Position: Q3 2026 in Review
First Trust Advisors opened a new position in Climb Bio (CLYM) in Q3 2026: 42,677 shares worth $490K. The stake represents ﹤0.01% of the portfolio and ranks #2435 among its holdings.
128 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.
- First Trust Advisors held 42,677 shares of Climb Bio worth $490K as of Q3 2026.
- Climb Bio was a new First Trust Advisors position in Q3 2026.
- Climb Bio made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #2435 holding.
- 128 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.
Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.